The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat

Brain Research

Volumn 888, Issue 2, 2001, Pages 302-305

  Turgeon, Sarah M ^a   Case, Lauren C ^a  

^a AMHERST COLLEGE   (United States)

Author keywords

Animal models; Prefrontal cortex; Schizophrenia; Striatum

Indexed keywords

AMPHETAMINE; PHENCYCLIDINE; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; GYRUS CINGULI; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHENCYCLIDINE; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035847210     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03056-0     Document Type: Article

References (15)

1. Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects
2. Observations on the psychotomimetic effects of sernyl
3. Stereotyped behavior patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei
4. The pharmacological and anatomical substrates of the amphetamine response in the rat
5. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: Evidence for a dopaminergic role in some PCP-induced behaviors
6. Effect of ibotentic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentration in the rat
7. Recent advances in the phencyclidine model of schizophrenia
8. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
9. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion
10. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat
11. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
12. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: A new model of schizophrenia
13. Effect if NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats
14. The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm
15. The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal c-Fos expression in the rat